Prelude Capital Management, LLC Vbi Vaccines Inc Transaction History
Prelude Capital Management, LLC
- $1.57 Billion
- Q3 2024
A detailed history of Prelude Capital Management, LLC transactions in Vbi Vaccines Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 12,900 shares of VBIV stock, worth $258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,900Holding current value
$258% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VBIV
# of Institutions
2Shares Held
688KCall Options Held
0Put Options Held
0About VBI Vaccines Inc
- Ticker VBIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 258,256,992
- Market Cap $5.17M
- Description
- VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...